Higgs Boson Pharmaceuticals Private Limited, a active private limited company, was established on 14 March 2012 in Irinjalakuda, Kerala, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24233KL2012PTC030755. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.48 M.
It upholds a compliant status. Its leadership includes Gorla Penchalrao Prasana Lakshmi (Director), Chandrasekharan Ramesh (Director), Parakunnath Krishnannamboodiri Mohankumar (Director). It holds ₹3.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at V/622 N,First Floor Sopanam Shopping Complex,North (Po), Irinjalakuda, Kerala, 680125.
U24233KL2012PTC030755
030755
14 March 2012
₹0.50 M
₹0.48 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Higgs Boson Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gorla Penchalrao Prasana Lakshmi | Director | 05 Mar 2013 | Current |
| Chandrasekharan Ramesh | Director | 19 May 2012 | Current |
| Parakunnath Krishnannamboodiri Mohankumar | Director | 14 Mar 2012 | Current |
| Adangazhipurath Vijayaraghavan | Director | 07 Aug 2012 | Current |
| Juby Joseph | Director | 07 Aug 2012 | Current |
| Thekkeppatt Santhoshkumar | Director | 07 Aug 2012 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Higgs Boson Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 0.82% increase. The company also saw a substantial improvement in profitability, with a 200.28% increase in profit. The company's net worth moved up by a moderate rise of 4.56%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Higgs Boson Pharmaceuticals had a promoter holding of 54.21% and a public holding of 45.79%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Feb 2023 | Indian Bank | ₹3.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Higgs Boson Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Higgs Boson Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Higgs Boson Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Higgs Boson Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Higgs Boson Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.
The activity A charge with Indian Bank amounted to Rs. 3.00 M with Charge ID 100689014 was registered on 17 Feb 2023. was completed.
The activity Gorla Penchalrao Prasana Lakshmi was appointed as a Director was appointed as a Director on 05 Mar 2013 & has been associated with this company since 12 years 8 months . was completed.
The activity Adangazhipurath Vijayaraghavan was appointed as a Director was appointed as a Director on 07 Aug 2012 & has been associated with this company since 13 years 3 months . was completed.
The activity Juby Joseph was appointed as a Director was appointed as a Director on 07 Aug 2012 & has been associated with this company since 13 years 3 months . was completed.
The CIN of Higgs Boson Pharmaceuticals Private Limited is U24233KL2012PTC030755.
Higgs Boson Pharmaceuticals Private Limited is headquartered at V/622 N,First Floor Sopanam Shopping Complex,North (Po), Irinjalakuda, Kerala, 680125.
Higgs Boson Pharmaceuticals Private Limited was incorporated on 14 March 2012.
The current directors of Higgs Boson Pharmaceuticals Private Limited are
The primary industry of Higgs Boson Pharmaceuticals Private Limited is Pharma.
Higgs Boson Pharmaceuticals Private Limited is unlisted.
The authorized capital of Higgs Boson Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.48 M.
The compliance status of Higgs Boson Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX